Basit öğe kaydını göster

Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient

dc.contributor.authorOzdogan, H
dc.contributor.authorYazici, H
dc.contributor.authorMasatlioglu, S
dc.contributor.authorSeyahi, E
dc.date.accessioned2021-03-05T14:55:06Z
dc.date.available2021-03-05T14:55:06Z
dc.date.issued2002
dc.identifier.citationSeyahi E., Ozdogan H., Masatlioglu S., Yazici H., "Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.20, 2002
dc.identifier.issn0392-856X
dc.identifier.othervv_1032021
dc.identifier.otherav_b9726e67-157f-4ea0-accf-a83d17c8efb3
dc.identifier.urihttp://hdl.handle.net/20.500.12627/123376
dc.description.abstractColchicine is the treatment of choice in familial Mediterranean fever (FMF) both for attacks and for prevention of secondary amyloidosis. The overall non-responder rate varies from 5-10 to 40 %. Thalidomide is known to blunt the acute phase response. We report the efficacy of the addition of thalidomide to colchicine in controlling the febrile attacks and acute phase response in a patient with FMF resistant to 2 mg colchicine per day.
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleSuccessful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient
dc.typeMakale
dc.relation.journalCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.contributor.department, ,
dc.identifier.volume20
dc.identifier.issue4
dc.contributor.firstauthorID165368


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster